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Introduction: Epilepsy and migraines are frequently observed as comorbidities, with the
occurrence of one disorder increasing the probability of the other. The aim of our study
was to evaluate the EEG characteristics by the type of headache and the implications
of EEGs in headache patients, comparing the clinical characteristics and treatments
between the headache patients with normal and abnormal EEGs.
Methods: We conducted a retrospective analysis reviewing the medical records of
259 patients with headaches who visited the pediatrics departments of five university
hospitals and underwent EEGs over a period of 3 years. Based on the data entered,
analyses of the following items were conducted: (1) comparison of the EEG abnormalities
by the type of headache and the characteristics of the EEG findings and (2) comparison
of the clinical characteristics between patients with normal and abnormal EEGs.
Results: Of the 259 patients, 31 showed abnormal EEGs, while 228 had normal EEGs.
Of the 31 patients with abnormal EEGs, 17 showed epileptiform discharges, and 11
showed rhythmic slowing. The frequency of EEG abnormalities was significantly high in
patients with migraines with auras than other types of headache. The Pediatric Migraine
Disability Assessment (PedMIDAS) score was significantly higher in the abnormal EEG
group compared with the normal EEG group (p = 0.001).
Conclusion: The results of this study suggest that the abnormal EEG group had more
significant disruptions in their daily lives due to headaches than the normal EEG group
and that patients with migraines with aura may need EEGs and they might also have
overlapping pathophysiologic mechanisms with epilepsy.
Keywords: headache, migraine, electroencephalogram (EEG), epileptiform discharge, preventive medication,
childhood
HIGHLIGHT
- Of the 259 patients, 31 (12%) showed abnormal EEGs, and 228 (88%) had normal findings.
- Of the 31 patients with abnormal EEGs, 17 showed epileptiform discharges (9 had focal spikes
and 8 had generalized spikes), and 11 showed rhythmic slowing (7 showed focal slowing, and 4
showed generalized slowing).
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- Migraines with aura showed more EEG abnormalities than
other types of headaches. In the patients with headaches with
epileptiform discharges, the PedMIDAS scores were higher,
and more anticonvulsants were prescribed prophylactically
than those of the normal group. These findings imply that
patients with migraines with aura may need EEGs, and they
might also have overlapping pathophysiologic mechanisms
with epilepsy, which can distinguish them from other types
of headaches.
INTRODUCTION
A primary headache is diagnosed through medical history and
physical examination. If a specific cause, such as a brain tumor
or epilepsy, is suspected, the patient undergoes brain imaging or
EEG testing to differentiate it from a secondary headache (1).
Epilepsy and migraines are frequently observed as comorbidities,
with the occurrence of one disorder increasing the probability
of the other (2–5). Migraine occurs in about one-fourth of the
patients with epilepsy, whereas epilepsy is present in 8–15%
of the patients with migraines (6). An EEG is a non-invasive
test and is useful for studies of pathophysiology in migraine
patients. For these reasons, it is often prescribed as a first-
line evaluation in migraine patients. However, the European
Federation of Neurological Societies (EFNS) guidelines for the
diagnosis of non-acute headaches report that an interictal EEG
is not routinely indicated for headache diagnosis (2). The usual
indication of an EEG in headache patients is for a differential
diagnosis when a serious doubt of epileptic seizure exists. This
kind of situation may especially emerge in headache patients
with atypical auras or episodic loss of consciousness (7). If a
patient has a headache with a visual aura or brainstem aura, an
EEG can be performed to differentiate its symptoms from those
of epilepsy. Piccinelli et al. reported on electroencephalogram
abnormalities in 12.8% of all children with headaches (8) and
more commonly in children manifesting migraines with aura (9).
Study of electroencephalogram variations in pediatric migraines
and tension-type headaches indicate that electroencephalogram
abnormalities are particularly prevalent in migraines, especially
during headache attacks (10).
The aim of our study was to evaluate the frequency
of EEG abnormalities in patients with headaches, the EEG
characteristics by the type of headache, and the implications of
EEGs in headache patients, comparing the clinical characteristics
and treatments between headache patients with normal and
abnormal EEGs.
METHODS AND MATERIALS
We conducted a retrospective analysis by reviewing the
medical records of 259 patients with headaches who
visited the department of pediatrics in five university
hospitals and underwent EEGs over a period of 3 years.
Electroencephalography was performed when the medical
history or physical examination of the patients showed symptoms
of a suspected seizure, such as visual or brainstem auras, the
patient’s lack of response to drug treatment, or continued
headaches. Patients with a past medical history of unprovoked
seizures, epilepsy, mental retardation, or significant abnormal
brain imaging—except incidental benign lesions, such as small
pineal cyst, arachnoid cyst, or venous anomaly—were excluded
from the study. We retrospectively reviewed the medical records
and collected information on age, sex, headache type, headache
frequency, severity, duration, EEG and neuroimaging results,
and preventive medications. The headache questionnaire form
in the medical record included a family history of headache and
characteristics of the headaches, such as frequency, duration,
location, signs, and accompanying symptoms, severity, and
disability caused by the headaches. The headaches were classified
according to the International Classification of Headache
Disorders (ICHD) criteria. Primary headaches were classified as
migraines without aura, migraines with aura, probable migraine,
tension headaches, probable tension-type headaches, and other
headaches. The severity of headache was assessed using a
visual analog scale (VAS: 0–10; 0 = no pain, 10 = most severe
pain). Disability in daily life from headaches was assessed using
Pediatric Migraine Disability Assessment (PedMIDAS) scores.
The scores reflect the number of days that school, home, social,
and recreational activities have been hampered by headaches
over the past 3 months. We evaluated the following items based
on the data of the headache patients who underwent EEGs: (1)
the frequency of EEG abnormalities in patients with headaches,
(2) comparison of the EEG abnormalities by the type of headache
and the characteristics of the EEG findings, (3) comparison of
the clinical characteristics and treatment between the patients
with normal and abnormal EEGs, and (4) the diagnostic value of
EEGs for patients with headaches.
Statistical analyses were performed using SPSS version
22 (IBM, Armonk, NY, USA). A chi-square test was
used to compare the frequency of the two groups and
mean comparisons were performed by t-tests for normal
distributions and by the Mann-Whitney U-test for non-
normally distributed data. The relationship between EEG
abnormality and PedMIDAS score or headache type was
TABLE 1 | Clinical characteristics of the headache patients with
electroencephalograms (EEG).
Headache patient with EEG (n = 259) Number (%)
Sex (male/female) 127/132 (1:1.03)
Age 11.3 ± 3.4
Headache type
Migraine without aura 108 (41.7)
Migraine with aura 41 (15.8)
Probable migraine 45 (17.4)
Tension-type headache 11 (4.2)
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FIGURE 1 | Classification of abnormal electroencephalogram (EEG) findings.



















Abnormal EEG 12 (11.1) 10 (24.4) 1 (2.2) 2 (18.2) 0 (0) 6 (12.2) 0.047
Epileptiform discharge Focal 6 2 1 0 0 0
General 2 2 0 2 0 2
Slowing Focal 3 1 0 0 0 3
General 3 1 0 0 0
Others 3 3 0 0 0 2
analyzed by logistic regression to adjust for age, sex, and
headache types.
In all cases, statistical significance was indicated by p < 0.05.
This study was approved by the Institutional Review Board of
Hallym University Dongtan Sacred Heart Hospital. Informed
consent was waived due to the retrospective nature of the study.
RESULTS
In 259 patients with headaches who underwent EEGs, the ratio of
males to females was 1:1.03 and themean age was 11.3± 3.4 years
old. The most common type of headache was migraines without
aura (108 patients), followed by 41 patients with migraines
with aura, 45 with probable migraines, 11 with tension-type
headaches, and 5 with probable tension-type headaches. EEGs
were mainly performed for the migraine patients. Of the 259
patients, 31 (12%) showed abnormal EEGs and 228 (88%) had
normal findings (Table 1). Of the 31 patients with abnormal
EEGs, 17 showed epileptiform discharges (9 had focal spikes,
and 8 had generalized spikes), and 11 showed rhythmic slowing
(7 showed focal slowing, and 4 showed generalized slowing)
(Figure 1). The frequency of EEG abnormalities was significantly
different according to headache types. Ten (24.2%) patients with
migraines with aura had abnormal EEGs, and 12 (11.1%) patients
with migraines without aura had abnormal EEGs (Table 2).
There were no differences in sex, age, or family history of
headache or epilepsy between the patient groups with normal
EEGs and abnormal EEGs. There were also no differences
in headache frequency, characteristics, duration, or location
(Table 3). The PedMIDAS score, which assesses the severity
of headaches, was significantly higher in the abnormal EEG
group than in the normal EEG group (p = 0.001) (Figure 2).
EEG abnormalities were significantly related to PedMIDAS score
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TABLE 3 | Comparison of clinical characteristics between headache patients with
normal and abnormal electroencephalograms (EEG).
Normal
(n = 228) (%)
Abnormal
(n = 31) (%)
P-value
Sex (M:F) 110:118 17:14 0.491
Age (years) 11.4 ± 3.4 10.5 ± 3.7 0.168
Family history of headache 82 (36) 14 (45.2) 0.320
Family history of epilepsy 3 (1.3) 0 (0.0) 0.521
Duration of illness 24 h 13 (9.4) 0 (0.0) 0.906
1 to <7 d 33 (23.9) 3 (37.5)
1 wk to <1 mo 23 (16.7) 1 (12.5)
1 mo to <6 mo 23 (16.7) 1 (12.5)
6 mo to 1 yr 18 (13.0 1 (12.5)
>1 yr 28 (20.3) 2 (25.0)
Frequency < 1/mo 31 (14.0) 1 (3.1) 0.745
1–3/mo 47 (21.3) 8 (25.8)
1/week 7 (3.2) 2 (6.5)
2–3/week 37 (16.0.7) 10 (32.3)
4–6/week 18 (8.1) 3 (9.7)
Every day 81 (36.7) 7 (22.6)
Headache
characteristics
Throbbing 77 (34.5) 4 (13.8) 0.227
Pressing 75 (33.6) 11 (37.9)
Squeezing 16 (7.2) 2 (6.9)
Stabbing 32 (14.3) 8 (27.6)
Pinching 1 (0.4) 0 (13.8)
Others 22 (9.9) 4 (12.9)
Duration < 1min 13 (5.9) 3 (10.3) 0.406
2–15min 6 (2.7) 1 (3.4)
16–30min 18 (8.1) 5 (17.2)
31–59min 62 (27.9) 5 (17.2)
1–72 h 117 (52.7) 14 (48.3)
>3 d 6 (2.7) 1 (3.4)
Location Bitemporal 57 (25.0) 7 (22.6) 0.220
Left temporal 23 (10.1) 5 (16.1)
Right temporal 17 (7.5) 6 (19.4)
Frontal 47 (20.6) 2 (6.5)
Vertex 13 (5.7) 4 (12.9)
Occipital 19 (8.3) 2 (6.5)
Periorbital 3 (1.3) 0 (0.0)
Posterior orbital 2 (0.9) 0 (0.0)
Whole 30 (13.2) 3 (9.7)
Others 13 (5.7) 1 (3.2)
and migraine with aura, respectively, when age, gender, and
headache types were adjusted with logistic regression analysis
(p = 0.007 adjusted odds ratio 1.034, 95% CI 1.009–1.060,
p = 0.030, adjusted odds ratio 2.874, 95% CI 1.109–7.447).
In a comparison of neuroimaging findings according to EEG
findings, MRIs were performed in 76.3% of the normal and 80.6%
of the abnormal EEG group and there was also no significant
difference between the two groups (Table 4). Brain tumors were
seen in one case of rhythmic focal slowing on the EEG but
were excluded from statistical analysis. Among the 17 headache
patients with epileptiform discharges, 8 patients had migraines
with aura, 5 had migraines without aura, 1 had a probable
migraine, 1 had migraine with aura and epilepsy, 1 had a tension-
type headache, and 1 had another type of headache (Table 5). The
most common preventive therapy for patients with normal EEGs
was amitriptyline, followed by flunarizine. The patients with
abnormal EEGs were treated most commonly with antiepileptic
drugs such as topiramate and valproate (Figure 3).
DISCUSSION
EEGs are not routinely recommended for headache patients
because they do not help with a primary headache diagnosis.
They are helpful only in patients with visual symptoms
or brainstem auras. Epilepsy and headaches often occur
simultaneously in the same patient. In patients with migraines,
epilepsy is present in 5.9% (range 1–17%), which is high
compared with the prevalence rate of 0.5–1% in the general
population (3). Similarly, 14.7% of the epilepsy patients have
migraines (range 8–24%), which is high compared with the
prevalence rate of 12% in the general population (4–6). Generally,
migraines occur in about one-fourth of the patients with epilepsy,
whereas epilepsy is present in 8–15% of the patients with
migraines (6). There are a few studies on the characteristics of
EEGs according to the type of headache and the implication of
EEGs for headache patients. EEG abnormalities were reported
to vary (8.8–20%) in pediatric headache patients (8, 10, 11),
and themost common abnormalities were epileptiform discharge
seen in 0.4–20% of the patients (12–18). Piccinelli et al.
reported electroencephalographic abnormalities in 12.8% of all
children with headaches (8). In our study, of the 259 headache
patients who underwent EEGs, 31 (12%) showed abnormal EEGs,
consisting of 17 (6.6%) epileptiform discharges (9 with focal
spikes and 8 with generalized spikes) and 11 with slowing (7 with
focal slowing and 4 with generalized slowing) while 228 (88%)
had normal findings.
The mechanism of the EEG abnormalities seen in headache
patients, unlike the general population, may be different in
migraine patients. Migraine patients have a potential for intrinsic
or genetic predispositions to cortical neuron hyperexcitability.
It has been suggested that the threshold of excitability of the
cortical neurons causing headaches in migraine patients is
lower than the threshold of cortical neuronal excitation causing
seizures in epilepsy patients (19). This hypothesis explains why
the prevalence of headaches in epilepsy patients was greater
than the prevalence of epilepsy in headache patients and the
underlying pathophysiologic mechanisms in abnormal EEGs in
headache patients.
The EEG abnormalities differed by the type of headache
(10) and the characteristics of the EEG findings. According
to a previous study, 36% (18/50) of the migraine patients
and 12% (6/50) of the tension-type headache patients revealed
specific electroencephalogram abnormalities in headache attack
electroencephalograms (p < 0.05). In electroencephalograms
taken during headache-free periods, 16% (8/50) of the migraine
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FIGURE 2 | Comparison of visual assessment score (VAS) and Pediatric Migraine Disability Assessment score (PedMIDAS) between patients with normal and
abnormal electroencephalograms (EEG).
TABLE 4 | Comparison of neuroimaging findings between patients with normal
















Result (total) Normal 162 (84.4) 19 (70.4) 0.174
Abnormal 30 (15.6) 8 (29.6)
CT, computed tomography; MRI, magnetic resonance image.
group and 2% (1/50) of the tension-type headache group revealed
abnormalities (p < 0.05) (17). In our study, according to
headache types, there was a significantly high frequency of EEG
abnormalities. Ten (24.4%) patients withmigraines with aura had
abnormal EEGs, and 12 (11.1%) patients with migraines without
aura had abnormal EEGs (Figure 2). These findings suggest
that patients with migraines with aura may need EEGs and
they might also have overlapping pathophysiologic mechanisms
with epilepsy, which can distinguish them from other types
of headaches.
There were no differences in the demographic data and
clinical characteristics of the headache patients with normal
and abnormal EEGs except for the PedMIDAS scores, which
assess the disability in daily life due to headaches. The scores
were statistically significantly higher in the abnormal EEG group
compared to the normal EEG group in our study (Figure 3).
Because of this, the headache patients with abnormal EEGs
had more significant disruptions in their daily lives due to
headaches than the patients with normal EEGs. We may need to
be concerned with focal slowing in the EEG that might be due to
brain tumors, as was seen in one case of rhythmic focal slowing in
the EEG in this study, and even with which cases were excluded
TABLE 5 | Acute and preventive medication of headache patients with
epileptiform discharges.
Medication Number Diagnosis
Focal No treatment 1 Probable migraine
Ibuprofen 2 Migaine without aura
Amitriptyline 1 Migraine without aura
Flunarizine 1 Migraine with aura
Valproate 2 Migraine with aura
Topiramate 2 Migraine without aura
Generalized Antibiotics 1 Others (sinusitis)
Ibuprofen 1 Migraine with aura
Valproate 2 Migraine with aura
Topiramate 2 Migraine with aura
Topiramate, oxcarbazepine 1 Migraine with aura with
epilepsy
Topiramate, levatriacetam, 1 Tension type headache
Oxcarbazepine
from statistical analysis. In a small population study, headache
patients with epileptiform discharge could effectively prevent
headaches by taking anticonvulsants (20). In our study, headache
patients with epileptiform discharges more frequently used
anticonvulsants as headache prevention drugs than the patients
with normal EEGs. Further prospective studies comparing
the effectiveness of preventive therapy with anticonvulsants
in patients with normal and epileptiform discharges in the
EEGs are needed. Rare cases have been reported of pure or
isolated ictal epileptic headaches occurring as the sole epileptic
manifestation (21–26). Rho et al. (27) found that one-third of
the patients with epilepsy and headaches had a headache first,
and more than half had a history of headaches when they first
visited a hospital for the evaluation of a seizure. Therefore,
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FIGURE 3 | Comparison of preventive therapy between patients with normal electroencephalograms (EEG) and epileptiform discharges.
especially in headache patients with epileptiform discharges
in the EEG, the occurrence of epilepsy should be monitored
by long-term follow-up. In view of the usefulness of EEGs
to differentiate epilepsy in headache patients, our study was
limited because only one of the 17 patients with epileptiform
discharges was finally diagnosed with epilepsy, but the follow-
up period was short, and anticonvulsants were usually used
as a headache prevention agent to suppress the occurrence of
seizures. Prospective follow-up studies of long-term prognosis
and the occurrence of epileptic convulsions in headache patients
with abnormal EEGs are needed because epilepsy patients
with comorbid migraines initially have a headache as the only
symptom (19, 28). Although the patient was not included this
study, headache was the only ictal symptom in an epileptic
patient who was diagnosed incidentally when an interictal
EEG was being recorded with the simultaneous onset of ictal
epileptiform discharges and headaches. A limitation of this study
was the retrospective nature of the chart review, which made it
difficult to determine the long-term prognosis of the patients with
abnormal EEGs.
CONCLUSION
We identified the frequency and characteristics of abnormal
EEGs according to the type of headache. Migraines with
aura showed more EEG abnormalities than other types of
headaches. In the patients with headaches with epileptiform
discharges, the PedMIDAS scores were higher than those
of the normal group, and more anticonvulsants were
prescribed prophylactically.
To determine the value of EEGs in headache patients,
more follow-up studies are required for headache patients with
epileptiform discharges.
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